Late chemo-intensification with cisplatin and 5-fluorouracil as an adjunct to radiotherapy: A pragmatic approach for locally advanced head and neck squamous cell carcinoma

Oral Oncology

Volumn 42, Issue 5, 2006, Pages 517-525

  Chufal, Kundan S ^a   Rastogi, Madhup ^b   Srivastava, Madhu ^b   Pant, M C ^b   Bhatt, M L B ^b  

^a Batra Hospital India   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Chemoboost; Cisplatin; Concurrent; Head and neck cancer; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DRUG FATALITY; DRUG INFUSION; DRUG RESPONSE; DYSPHAGIA; EDEMA; FEASIBILITY STUDY; FEMALE; HOARSENESS; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RECURRENCE RISK; SKIN MANIFESTATION; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL; THROMBOCYTOPENIA; TUMOR BIOPSY; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33748122689     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.10.004     Document Type: Article

References (31)

1. Dubois J.B., Guerrier B., Di Ruggiero J.M., and Pourquier H. Cancer of the piriform sinus: treatment by radiation therapy alone and with surgery. Radiology 160 (1986) 831-836
2. Kramer S., Gelber R.D., Snow J.B., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10 (1987) 19-30
3. Amdur R.J., Parsons J.T., Mendenhall W.M., Million R.R., Stringer S.P., and Cassisi N.J. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 16 (1989) 25-36
4. Peters L.J., Goepfert H., Ang K.K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26 (1993) 3-11
5. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., and Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. J Natl Cancer Inst 88 (1996) 890-899
6. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. New Engl J Med 324 (1991) 1685-1690
7. Christiansen H., Hermann R.M., Hille A., Weiss E., Nitsche M., Martin A., et al. Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C. Head Neck 26 10 (2004) 845-853
8. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New Engl J Med 349 (2003) 2091-2098
9. Adelstein D.J., Li Y., Adams G.L., et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21 1 (2003) 92-98
10. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
11. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88 (2000) 876-883
12. Taylor S.G., Murthy A.K., Griem K.L., Recine D.C., Kiel K., Blendowski C., et al. Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-year analysis of results. Head Neck 19 (1997) 684-691
13. McGinn C.J., and Kinsella T.J. The experimental and clinical rationale for the use of S-phase-specific radiosensitizer to overcome tumor cell repopulation. Semin Oncol 19 4 Suppl. 11 (1992) 21-28
14. McGinn C.J., Miller E.M., Lindstrom M.J., Kunugi K.A., Johnston P.G., and Kinsella T.J. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization. Int J Radiat Oncol Biol Phys 30 4 (1994) 851-859
15. Peters L.J., and Withers H.R. Applying radiobiological principles to combined modality treatment of head and neck cancer: the time factor. Int J Radiol Biol Phys 39 (1997) 831-836
16. Brown J.M. Therapeutic targets in radiotherapy. Int J Radiat Oncol Biol Phys 49 (2001) 319-326
17. Thomlinson RH. Reoxygenaation as a function of tumor size and histopathological type. In: Proceedings of the Carmel conference on time and dose relationship in radiation biology as applied to radiotherapy. BNL report 50203(C-57) Upton NY, 1996. p. 242-54.
18. Corry J., Rischin D., Smith J.G., D'Costa I.A., Huges P.G., et al. Radiation with concurrent late chemotherapy intensification (chemoboost) for locally advanced head and neck cancer. Radiother Oncol 54 2 (2000) 123-127
19. Garden A.S., Glisson B.S., Ang K.K., Morrison W.H., Lippman S.M., et al. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol 17 8 (1999) 2390-2395
20. Rischin D., Peters L., Fisher R., Macann A., Denham J., et al. Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 23 1 (2005) 79-87
21. Ang K.K., Peters L.J., Weber R.S., et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys (1990) 1339-1345
22. Izmirli M., Yaman F., Buyukpolat M.Y., Yoney A., and Unsal M. An accelerated radiotherapy scheme using a concomitant boost technique for the treatment of unresectable stage III non-small cell lung cancer. Jpn J Clin Oncol 10 5 (2005)
23. Lu J.J., Shakespeare T.P., Thiagarajan A., Zhang X., Liang L., and Tan S. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity. Laryngoscope 115 5 (2005) 806-810
24. Ang K.K., Harris J., Garden A.S., Trotti A., Jones C.U., Carrascosa L., et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol 23 13 (2005) 3008-3015
25. Terhaard C.H., Kal H.B., and Hordijk G.J. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3. Int J Radiat Oncol Biol Phys 62 1 (2005) 62-69
26. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
27. Vikram B., Strong E.W., Shah J.P., and Spiro R. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 6 (1984) 720-723
28. Vikram B., Strong E.W., Shah J.P., and Spiro R. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6 (1984) 730-733
29. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., and Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44 (1997) 123-136
30. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44 (1997) 111-121
31. Jackson S.M., Weir L.M., Hay J.H., Tsang V.H.Y., and Durham J.S. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43 (1997) 39-46